Skip to content

DAFNA Capital Management LLC

Follow

13F filer, CIK 1389933, LOS ANGELES, CA

DAFNA Capital Management LLC reported $468,054,240 across 87 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 57.94% of the portfolio.

Accepted , ingested 13F-HR 0001389933-26-000010

Period
2026-09-30
Reported value
$468M
Holdings
87
Top 10 weight
57.94%
New
4
Sold out
5

Part of the filer group DAFNA Capital Management LLC

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RAPPadded+66,900$2.25M
NGNEadded+61,500$1.71M
EPRXadded+178,967$1.63M
CMPSadded+124,000$1.54M
RNAadded+172,076$1.42M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
RVMDreduced-75,500-$15.5M
XBIreduced-45,000-$7.1M
IBBreduced-31,000-$6.53M
ATRCreduced-74,684-$4.2M
HELPreduced-338,359-$4.16M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001389933-26-000010, largest first. % of portfolio is the value over $468,054,240, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 631,176 shares; 2025Q1: 656,176 shares; 2025Q2: 677,176 shares; 2025Q3: 657,176 shares; 2025Q4: 604,514 shares; 2026Q1: 580,678 shares; 2026Q2: 562,630 shares; 2026Q3: 487,130 shares 487,130$100M21.36%-75,500Timeline
ATRCATRICURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 641,673 shares; 2025Q1: 592,273 shares; 2025Q2: 592,273 shares; 2025Q3: 592,273 shares; 2025Q4: 597,431 shares; 2026Q1: 597,431 shares; 2026Q2: 597,431 shares; 2026Q3: 522,747 shares 522,747$29.4M6.28%-74,684Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 243,210 shares; 2025Q1: 711,046 shares; 2025Q2: 811,046 shares; 2025Q3: 811,046 shares; 2025Q4: 811,046 shares; 2026Q1: 2,418,882 shares; 2026Q2: 2,011,952 shares; 2026Q3: 2,135,952 shares 2,135,952$26.6M5.68%+124,000Timeline
XBISPDR SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 397,505 shares; 2025Q1: 404,505 shares; 2025Q2: 415,505 shares; 2025Q3: 401,505 shares; 2025Q4: 336,505 shares; 2026Q1: 318,505 shares; 2026Q2: 196,505 shares; 2026Q3: 151,505 shares 151,505$23.9M5.1%-45,000Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 54,998 shares; 2025Q4: 74,998 shares; 2026Q1: 165,178 shares; 2026Q2: 318,380 shares; 2026Q3: 323,380 shares 323,380$19.6M4.18%+5,000Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 498,827 shares; 2025Q1: 589,330 shares; 2025Q2: 619,090 shares; 2025Q3: 539,923 shares; 2025Q4: 506,740 shares; 2026Q1: 476,740 shares; 2026Q2: 497,240 shares; 2026Q3: 438,740 shares 438,740$16.9M3.6%-58,500Timeline
STXSSTEREOTAXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 13,680,554 shares; 2025Q1: 13,680,554 shares; 2025Q2: 13,680,554 shares; 2025Q3: 13,680,554 shares; 2025Q4: 13,680,554 shares; 2026Q1: 13,680,554 shares; 2026Q2: 13,680,554 shares; 2026Q3: 13,680,554 shares 13,680,554$16.8M3.6%02026-11-09, 13D/A: 15,628,395 shares, 15.3% of the class, 13D/A filed 2026-11-12 Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 127,900 shares; 2025Q2: 168,500 shares; 2025Q3: 168,500 shares; 2025Q4: 318,500 shares; 2026Q1: 318,500 shares; 2026Q2: 739,014 shares; 2026Q3: 744,014 shares 744,014$15.4M3.29%+5,000Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 48,469 shares; 2026Q3: 49,969 shares 49,969$11.4M2.43%+1,500Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 254,217 shares; 2025Q1: 625,126 shares; 2025Q2: 627,626 shares; 2025Q3: 627,626 shares; 2025Q4: 431,329 shares; 2026Q1: 443,829 shares; 2026Q2: 441,829 shares; 2026Q3: 439,829 shares 439,829$11.4M2.43%-2,000Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 398,100 shares; 2025Q1: 398,100 shares; 2025Q2: 398,100 shares; 2025Q3: 394,940 shares; 2025Q4: 370,997 shares; 2026Q1: 217,497 shares; 2026Q2: 171,998 shares; 2026Q3: 171,998 shares 171,998$11.3M2.42%0Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 187,140 shares; 2025Q1: 183,140 shares; 2025Q2: 238,140 shares; 2025Q3: 213,736 shares; 2025Q4: 159,736 shares; 2026Q1: 112,236 shares; 2026Q2: 226,819 shares; 2026Q3: 221,819 shares 221,819$9.01M1.92%-5,000Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 71,615 shares; 2025Q1: 71,615 shares; 2025Q2: 70,615 shares; 2025Q3: 70,615 shares; 2025Q4: 70,615 shares; 2026Q1: 70,615 shares; 2026Q2: 57,769 shares; 2026Q3: 62,716 shares 62,716$8.9M1.9%+4,947Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,400 shares; 2025Q1: 11,900 shares; 2025Q2: 9,900 shares; 2025Q3: 6,870 shares; 2025Q4: 6,870 shares; 2026Q1: 10,870 shares; 2026Q2: 61,870 shares; 2026Q3: 67,870 shares 67,870$8.85M1.89%+6,000Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 273,739 shares; 2025Q1: 273,739 shares; 2025Q2: 287,939 shares; 2025Q3: 287,939 shares; 2025Q4: 287,939 shares; 2026Q1: 250,772 shares; 2026Q2: 250,772 shares; 2026Q3: 204,772 shares 204,772$7.62M1.63%-46,000Timeline
AXGNAXOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 846,882 shares; 2025Q1: 680,782 shares; 2025Q2: 741,782 shares; 2025Q3: 742,282 shares; 2025Q4: 476,826 shares; 2026Q1: 249,960 shares; 2026Q2: 208,960 shares; 2026Q3: 179,960 shares 179,960$7.54M1.61%-29,000Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 65,552 shares; 2025Q1: 65,552 shares; 2025Q2: 65,552 shares; 2025Q3: 65,552 shares; 2025Q4: 88,279 shares; 2026Q1: 86,279 shares; 2026Q2: 86,279 shares; 2026Q3: 86,279 shares 86,279$7.45M1.59%0Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 542,002 shares; 2025Q1: 544,502 shares; 2025Q2: 543,602 shares; 2025Q3: 500,702 shares; 2025Q4: 277,855 shares; 2026Q1: 217,355 shares; 2026Q2: 335,255 shares; 2026Q3: 331,290 shares 331,290$6.23M1.33%-3,965Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 371,434 shares; 2025Q1: 371,434 shares; 2025Q2: 371,434 shares; 2025Q3: 1,027,764 shares; 2025Q4: 939,164 shares; 2026Q1: 2,029,164 shares; 2026Q2: 2,008,164 shares; 2026Q3: 1,888,155 shares 1,888,155$6.03M1.29%-120,009Timeline
TNDMTANDEM DIABETES CARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 223,208 shares; 2025Q1: 294,208 shares; 2025Q2: 294,208 shares; 2025Q3: 355,208 shares; 2025Q4: 355,208 shares; 2026Q1: 355,208 shares; 2026Q2: 355,208 shares; 2026Q3: 355,208 shares 355,208$5.79M1.24%0Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 105,500 shares; 2025Q1: 212,001 shares; 2025Q2: 317,001 shares; 2025Q3: 317,001 shares; 2025Q4: 261,583 shares; 2026Q1: 421,733 shares; 2026Q2: 284,955 shares; 2026Q3: 299,955 shares 299,955$5.58M1.19%+15,000Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 75,000 shares; 2025Q4: 75,000 shares; 2026Q1: 75,000 shares; 2026Q2: 75,000 shares; 2026Q3: 141,900 shares 141,900$4.77M1.02%+66,900Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 107,996 shares; 2025Q1: 169,996 shares; 2025Q2: 191,493 shares; 2025Q3: 191,493 shares; 2025Q4: 150,524 shares; 2026Q1: 150,524 shares; 2026Q2: 149,524 shares; 2026Q3: 135,524 shares 135,524$4.58M0.98%-14,000Timeline
INGNINOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 208,790 shares; 2025Q1: 458,065 shares; 2025Q2: 605,625 shares; 2025Q3: 605,625 shares; 2025Q4: 827,071 shares; 2026Q1: 845,179 shares; 2026Q2: 845,179 shares; 2026Q3: 845,179 shares 845,179$4.45M0.95%0Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 51,500 shares; 2025Q1: 51,500 shares; 2025Q2: 51,096 shares; 2025Q3: 30,375 shares; 2025Q4: 27,974 shares; 2026Q1: 56,635 shares; 2026Q2: 89,032 shares; 2026Q3: 150,532 shares 150,532$4.19M0.89%+61,500Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 120,700 shares; 2025Q1: 94,200 shares; 2025Q2: 103,748 shares; 2025Q3: 134,748 shares; 2025Q4: 130,248 shares; 2026Q1: 139,482 shares; 2026Q2: 101,266 shares; 2026Q3: 101,266 shares 101,266$4.1M0.88%0Timeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,704,232 shares; 2025Q1: 1,704,232 shares; 2025Q2: 1,704,232 shares; 2025Q3: 1,704,232 shares; 2025Q4: 2,793,586 shares; 2026Q1: 2,434,353 shares; 2026Q2: 2,400,458 shares; 2026Q3: 2,386,750 shares 2,386,750$4.08M0.87%-13,708Timeline
KIDSORTHOPEDIATRICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 95,659 shares; 2026Q2: 189,130 shares; 2026Q3: 179,130 shares 179,130$3.99M0.85%-10,000Timeline
LKFTLAKEFRONT BIOTHERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 130,175 shares; 2025Q1: 130,175 shares; 2025Q2: 130,175 shares; 2025Q3: 130,175 shares; 2025Q4: 130,175 shares; 2026Q1: 130,175 shares; 2026Q2: 130,175 shares; 2026Q3: 130,175 shares 130,175$3.86M0.82%0Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 171,097 shares; 2025Q1: 443,998 shares; 2025Q2: 501,972 shares; 2025Q3: 169,791 shares; 2025Q4: 108,875 shares; 2026Q1: 130,875 shares; 2026Q2: 130,875 shares; 2026Q3: 146,135 shares 146,135$3.8M0.81%+15,260Timeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 239,553 shares; 2026Q3: 232,763 shares 232,763$3.72M0.8%-6,790Timeline
EPRXEUPRAXIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 225,600 shares; 2026Q3: 404,567 shares 404,567$3.68M0.79%+178,967Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 24,518 shares; 2025Q4: 68,518 shares; 2026Q1: 68,518 shares; 2026Q2: 68,518 shares; 2026Q3: 108,118 shares 108,118$3.5M0.75%+39,600Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,240,118 shares; 2025Q1: 1,380,118 shares; 2025Q2: 1,380,118 shares; 2025Q3: 1,380,118 shares; 2025Q4: 1,380,118 shares; 2026Q1: 1,370,118 shares; 2026Q2: 2,000,000 shares; 2026Q3: 2,000,000 shares 2,000,000$3.2M0.68%0Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 667,000 shares; 2025Q1: 558,255 shares; 2025Q2: 218,255 shares; 2025Q3: 218,255 shares; 2025Q4: 418,255 shares; 2026Q1: 430,248 shares; 2026Q2: 400,248 shares; 2026Q3: 380,248 shares 380,248$3.17M0.68%-20,000Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 27,000 shares; 2026Q3: 26,912 shares 26,912$3.01M0.64%-88Timeline
AQSTAQUESTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 127,000 shares; 2025Q1: 142,000 shares; 2025Q2: 142,000 shares; 2025Q3: 512,589 shares; 2025Q4: 375,915 shares; 2026Q1: 368,415 shares; 2026Q2: 645,915 shares; 2026Q3: 640,915 shares 640,915$2.97M0.63%-5,000Timeline
RNAATRIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 128,000 shares; 2026Q3: 300,076 shares 300,076$2.48M0.53%+172,076Timeline
IBBISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 102,500 shares; 2025Q1: 102,500 shares; 2025Q2: 102,500 shares; 2025Q3: 102,500 shares; 2025Q4: 68,095 shares; 2026Q1: 62,095 shares; 2026Q2: 42,595 shares; 2026Q3: 11,595 shares 11,595$2.44M0.52%-31,000Timeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,000 shares; 2025Q3: not reported; 2025Q4: 120,000 shares; 2026Q1: 120,000 shares; 2026Q2: 120,000 shares; 2026Q3: 120,000 shares 120,000$2.19M0.47%0Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,567,561 shares; 2025Q1: 1,567,561 shares; 2025Q2: 1,567,561 shares; 2025Q3: 1,567,561 shares; 2025Q4: 1,567,561 shares; 2026Q1: 1,567,561 shares; 2026Q2: 1,530,361 shares; 2026Q3: 1,312,530 shares 1,312,530$2.18M0.47%-217,831Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 455,018 shares; 2026Q1: 498,361 shares; 2026Q2: 514,061 shares; 2026Q3: 175,702 shares 175,702$2.16M0.46%-338,359Timeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,500 shares; 2025Q1: 11,000 shares; 2025Q2: 11,000 shares; 2025Q3: 11,000 shares; 2025Q4: 16,000 shares; 2026Q1: 15,000 shares; 2026Q2: 14,000 shares; 2026Q3: 14,000 shares 14,000$2.03M0.43%0Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 64,516 shares; 2025Q1: 64,516 shares; 2025Q2: 64,516 shares; 2025Q3: 64,516 shares; 2025Q4: 59,516 shares; 2026Q1: 59,516 shares; 2026Q2: 59,516 shares; 2026Q3: 54,516 shares 54,516$1.78M0.38%-5,000Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 35,000 shares; 2026Q2: 65,000 shares; 2026Q3: 65,000 shares 65,000$1.77M0.38%0Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 912,928 shares; 2025Q1: 912,928 shares; 2025Q2: 912,928 shares; 2025Q3: 798,351 shares; 2025Q4: 908,351 shares; 2026Q1: 908,351 shares; 2026Q2: 908,351 shares; 2026Q3: 908,351 shares 908,351$1.68M0.36%0Timeline
TELATELA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,441,029 shares; 2025Q1: 1,441,029 shares; 2025Q2: 1,441,029 shares; 2025Q3: 1,441,029 shares; 2025Q4: 1,441,029 shares; 2026Q1: 1,441,029 shares; 2026Q2: 1,441,029 shares; 2026Q3: 1,441,029 shares 1,441,029$1.66M0.35%0Timeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 143,764 shares; 2026Q1: 171,006 shares; 2026Q2: 171,006 shares; 2026Q3: 155,579 shares 155,579$1.59M0.34%-15,427Timeline
NGENNERVGEN PHARMA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,050,000 shares; 2026Q3: 810,862 shares 810,862$1.55M0.33%-239,138Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 35,500 shares; 2025Q1: 59,000 shares; 2025Q2: 59,000 shares; 2025Q3: 59,000 shares; 2025Q4: 37,000 shares; 2026Q1: 46,500 shares; 2026Q2: 46,500 shares; 2026Q3: 46,500 shares 46,500$1.45M0.31%0Timeline
PROFPROFOUND MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 285,710 shares; 2026Q1: 263,005 shares; 2026Q2: 260,360 shares; 2026Q3: 225,094 shares 225,094$1.31M0.28%-35,266Timeline
MDWDMEDIWOUND LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 64,479 shares; 2025Q1: 64,479 shares; 2025Q2: 64,479 shares; 2025Q3: 113,612 shares; 2025Q4: 113,612 shares; 2026Q1: 94,405 shares; 2026Q2: 94,405 shares; 2026Q3: 94,405 shares 94,405$1.3M0.28%0Timeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 102,600 shares; 2026Q3: 102,100 shares 102,100$1.28M0.27%-500Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 393,083 shares; 2025Q1: 378,083 shares; 2025Q2: 378,083 shares; 2025Q3: 358,083 shares; 2025Q4: 340,859 shares; 2026Q1: 377,059 shares; 2026Q2: 377,059 shares; 2026Q3: 377,059 shares 377,059$1.27M0.27%0Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 17,200 shares; 2025Q4: 8,600 shares; 2026Q1: 18,200 shares; 2026Q2: 18,200 shares; 2026Q3: 18,200 shares 18,200$1.26M0.27%0Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 230,000 shares; 2026Q2: 438,407 shares; 2026Q3: 438,407 shares 438,407$1.19M0.25%0Timeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 550,000 shares; 2026Q1: 550,000 shares; 2026Q2: 525,000 shares; 2026Q3: 500,000 shares 500,000$1.19M0.25%-25,000Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 146,500 shares; 2025Q1: 309,200 shares; 2025Q2: 371,523 shares; 2025Q3: 83,490 shares; 2025Q4: 38,490 shares; 2026Q1: 38,490 shares; 2026Q2: 44,490 shares; 2026Q3: 44,490 shares 44,490$1.12M0.24%0Timeline
PYPDPOLYPID LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 291,273 shares; 2025Q1: 291,273 shares; 2025Q2: 207,900 shares; 2025Q3: 207,900 shares; 2025Q4: 207,900 shares; 2026Q1: 207,900 shares; 2026Q2: 207,900 shares; 2026Q3: 207,900 shares 207,900$1.1M0.23%0Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 266,038 shares 266,038$1.09M0.23%newTimeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 272,812 shares; 2026Q1: 117,812 shares; 2026Q2: 297,812 shares; 2026Q3: 257,637 shares 257,637$1.09M0.23%-40,175Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 220,235 shares; 2025Q1: 220,235 shares; 2025Q2: 235,235 shares; 2025Q3: 235,235 shares; 2025Q4: 955,235 shares; 2026Q1: 845,735 shares; 2026Q2: 137,593 shares; 2026Q3: 77,593 shares 77,593$1.04M0.22%-60,000Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 245,000 shares; 2025Q1: 245,000 shares; 2025Q2: 245,000 shares; 2025Q3: 235,000 shares; 2025Q4: 261,138 shares; 2026Q1: 225,860 shares; 2026Q2: 116,960 shares; 2026Q3: 116,960 shares 116,960$1.03M0.22%0Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 32,896 shares; 2026Q3: 98,500 shares 98,500$815K0.17%+65,604Timeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 344,820 shares 344,820$803K0.17%newTimeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 88,790 shares; 2025Q1: 95,290 shares; 2025Q2: not reported; 2025Q3: 140,500 shares; 2025Q4: 190,065 shares; 2026Q1: 139,285 shares; 2026Q2: 164,285 shares; 2026Q3: 182,785 shares 182,785$788K0.17%+18,500Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 16,000 shares; 2026Q1: 61,100 shares; 2026Q2: 47,100 shares; 2026Q3: 51,100 shares 51,100$768K0.16%+4,000Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 448,368 shares; 2025Q1: 463,368 shares; 2025Q2: 463,368 shares; 2025Q3: 463,368 shares; 2025Q4: 235,868 shares; 2026Q1: 235,868 shares; 2026Q2: 120,568 shares; 2026Q3: 69,068 shares 69,068$740K0.16%-51,500Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,500 shares; 2025Q1: 10,500 shares; 2025Q2: 7,000 shares; 2025Q3: 7,000 shares; 2025Q4: 7,000 shares; 2026Q1: 7,000 shares; 2026Q2: 7,000 shares; 2026Q3: 7,000 shares 7,000$688K0.15%0Timeline
SCYXSCYNEXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 135,868 shares; 2026Q3: 135,868 shares 135,868$671K0.14%0Timeline
ACETADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 93,812 shares; 2026Q1: 93,812 shares; 2026Q2: 93,812 shares; 2026Q3: 93,812 shares 93,812$670K0.14%0Timeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 32,400 shares; 2026Q3: 32,400 shares 32,400$654K0.14%0Timeline
QNRXQUOIN PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 132,156 shares 132,156$603K0.13%newTimeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 107,773 shares; 2026Q3: 83,248 shares 83,248$568K0.12%-24,525Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 487,000 shares; 2026Q2: 487,000 shares; 2026Q3: 487,000 shares 487,000$526K0.11%0Timeline
EDITEDITAS MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 170,470 shares; 2026Q3: 180,470 shares 180,470$464K0.1%+10,000Timeline
ARAYACCURAY INC DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,222,358 shares; 2025Q1: 1,222,358 shares; 2025Q2: 1,222,358 shares; 2025Q3: 1,222,358 shares; 2025Q4: 1,395,508 shares; 2026Q1: 1,680,508 shares; 2026Q2: 1,680,508 shares; 2026Q3: 1,680,508 shares 1,680,508$454K0.1%0Timeline
CGENCOMPUGEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 447,202 shares; 2025Q1: 272,402 shares; 2025Q2: 272,402 shares; 2025Q3: 272,402 shares; 2025Q4: 272,402 shares; 2026Q1: 257,783 shares; 2026Q2: 168,232 shares; 2026Q3: 168,232 shares 168,232$400K0.09%0Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 586,667 shares; 2025Q1: 586,667 shares; 2025Q2: 425,616 shares; 2025Q3: 179,316 shares; 2025Q4: 179,316 shares; 2026Q1: 179,316 shares; 2026Q2: 179,316 shares; 2026Q3: 179,316 shares 179,316$348K0.07%0Timeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 186,717 shares; 2025Q1: 304,752 shares; 2025Q2: 300,452 shares; 2025Q3: 126,859 shares; 2025Q4: 126,859 shares; 2026Q1: 111,859 shares; 2026Q2: 111,859 shares; 2026Q3: 89,659 shares 89,659$320K0.07%-22,200Timeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 193,638 shares; 2026Q2: 170,053 shares; 2026Q3: 170,053 shares 170,053$201K0.04%0Timeline
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 47,319 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 300,000 shares; 2026Q3: 300,000 shares 300,000$181K0.04%0Timeline
KZIAKAZIA THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 15,700 shares 15,700$151K0.03%newTimeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 74,650 shares; 2026Q3: 74,650 shares 74,650$149K0.03%0Timeline
VRCAVERRICA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 173,451 shares; 2026Q1: 153,712 shares; 2026Q2: 23,750 shares; 2026Q3: 23,750 shares 23,750$114K0.02%0Timeline
KARDKARDIGAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,000 shares; 2026Q3: 5,000 shares 5,000$73.8K0.02%0Timeline
ADCTADC THERAPEUTICS SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 224,081 shares; 2025Q1: 224,081 shares; 2025Q2: 122,081 shares; 2025Q3: 122,081 shares; 2025Q4: 77,081 shares; 2026Q1: 72,081 shares; 2026Q2: 77,081 shares; 2026Q3: 57,081 shares 57,081$69.6K0.01%-20,000Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MBXMBX BIOSCIENCES INC11,809$652Kshares
ARTVARTIVA BIOTHERAPEUTICS INC67,101$651Kshares
OBIOORCHESTRA BIOMED HLDGS INC126,841$547Kshares
NVCTNUVECTIS PHARMA INC20,000$368Kshares
BCYCBICYCLE THERAPEUTICS PLC64,492$273Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001389933-26-000010 base2026-11-16